Organogenesis Holdings (ORGO) Receives a Buy From Cantor Fitzgerald
Organogenesis Hldgs Analyst Ratings
Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating
Buy Rating Affirmed for Organogenesis Holdings Amid Stable Product Pricing and Positive Market Dynamics
Organogenesis Hldgs Analyst Ratings
Organogenesis Holdings: A Buy Rating With Anticipated Turnaround and Growth Prospects
Organogenesis Hldgs Analyst Ratings
BTIG Maintains Buy on Organogenesis Hldgs, Raises Price Target to $6
Organogenesis Hldgs Analyst Ratings
Morgan Stanley Maintains Equal-Weight on Organogenesis Hldgs, Raises Price Target to $3.5
Organogenesis Hldgs Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Organogenesis Holdings (ORGO) and Immuneering (IMRX)
Analysts Offer Insights on Healthcare Companies: Organogenesis Holdings (ORGO) and Femasys (FEMY)
Organogenesis Holdings (ORGO) Receives a Buy From BTIG
BTIG Sticks to Their Buy Rating for Organogenesis Holdings (ORGO)
Morgan Stanley Maintains Equal-Weight on Organogenesis Hldgs, Lowers Price Target to $3
Organogenesis Hldgs Analyst Ratings
BTIG Maintains Buy on Organogenesis Hldgs, Lowers Price Target to $4
Organogenesis Hldgs Analyst Ratings
Organogenesis Holdings (ORGO) Gets a Buy From BTIG
No Data
No Data